Tashkent, Uzbekistan (UzDaily.com) -- The leadership of the National Chamber of Innovative Healthcare of Uzbekistan held negotiations with the representatives of AstraZeneca on cooperation opportunities in several directions.

“There is an opportunity to attract experts who recently took part in updating Russian clinical protocols in endocrinology. By attracting such experts of the international level, in Uzbekistan, it is possible to accelerate the development and adoption of truly effective modern clinical protocols and guidelines. And we are ready to support you”, said the Head of the Strategic Partnership Development Department of AstraZeneca in the Eurasian Cluster, Zamira Kulmanbetova.

The company’s representative noted that today the reforms in Uzbekistan’s medical sector contribute to the emergence of modern pharmaceuticals in the country, developed using high technologies. In particular, this company, which has not been present in Uzbekistan for a long time, has registered a number of its latest developments in the country over the past two years, including drugs for cancer patients.

The parties discussed the possibilities of cooperation between the parties in projects on the preferential pharmaceutical provision of certain groups of the population.